Vtv Therapeutics announces FDA orphan drug designation for HPPD in sickle cell disease
VTVT•Vtv Therapeutics said the FDA granted orphan drug designation to HPPD, which is under investigation as a treatment for sickle cell disease.
1. Designation announced
Vtv Therapeutics said the FDA granted orphan drug designation to HPPD, which is under investigation as a treatment for sickle cell disease.
